Welcome to our dedicated page for Royce Micro-Cap Trust SEC filings (Ticker: RMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Royce Micro-Cap Trust, Inc. filings document the proxy and governance record of a closed-end diversified management investment company with common stock listed on the New York Stock Exchange. Its definitive proxy materials provide the formal notice for the annual meeting of stockholders and the Schedule 14A framework for stockholder voting.
The filing record centers on annual-meeting materials, registrant-filed proxy statements, common stockholder participation, and governance disclosures associated with the Fund’s public-company obligations.
ROYCE MICRO-CAP TRUST, INC. secretary John E. Denneen made an open-market purchase of 3,249 shares of Common Stock at $13.97 per share. After this transaction, he directly holds a total of 8,232 shares, indicating a modest increase in his personal stake.
ROYCE MICRO-CAP TRUST, INC. president and director Christopher D. Clark made an open-market purchase of 6,500 shares of the company’s common stock. The shares were bought at a price of $11.48 per share. Following this transaction, his directly owned stake increased to 68,648 common shares.
Royce Micro-Cap Trust, Inc. reported that President and director Christopher D. Clark made an open-market purchase of 6,500 shares of the company’s Common Stock at a price of $11.48 per share. Following this transaction, he directly holds 68,648 shares of Common Stock.
RMT submitted a Form N-CEN annual report for a registered investment company, providing fund-level operational disclosures required by the Investment Company Act of 1940.
The filing lists aggregate brokerage commissions paid of $1,198,186.46 during the reporting period and identifies principal transactions with a largest reported dealer turnover of $2,814,934,123.59.
Royce Micro-Cap Trust, Inc. files its 2025 Certified Shareholder Report and 2025 Annual Review covering January 1, 2025–December 31, 2025. The report includes the Funds’ annual review, performance tables, schedules of investments, financial statements, and management discussion.
Royce Micro-Cap Trust advanced 16.6% on a net asset value basis in 2025 versus the Russell 2000’s 12.8%. The report notes portfolio positioning, sector contributors and detractors, Fund diagnostics (net assets of $631 million, NAV $11.79, market price $10.43, turnover 41%), and the Fund’s managed distribution policy described earlier in the materials.
Saba Capital Management and affiliates have disclosed a significant position in Royce Micro-Cap Trust, Inc. The group, including Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, reports beneficial ownership of 2,628,462 common shares, representing 5% of the outstanding stock, based on 52,592,863 shares outstanding as of 8/5/25. They state that about $26,301,407 was paid to acquire these shares, using investor subscription proceeds, related appreciation, and ordinary-course margin borrowings.
The filing says the shares were acquired in the ordinary course for investment because they believe the stock is undervalued. The reporting persons may engage with management, the board, and other shareholders on topics such as operations, governance, board appointments, capitalization, trading at a discount to net asset value, and the open or closed end nature and potential liquidation timing of the trust. They may consider actions including proxy solicitation, shareholder proposals, or board nominations, and may increase, reduce, or hedge their position over time.
Royce Micro-Cap Trust, Inc. (RMT) insider filed a Form 4 reporting a sale of common stock. On 11/05/2025, the reporting person executed a Code S transaction, disposing of 200,000 shares at a price of $10.27 per share.
Following the reported transaction, the filing shows 596,926 shares beneficially owned directly. It also lists indirect holdings of 457,070 shares held in the Royce Charitable Trust and 26,074 shares held through a family investment entity. A footnote states the reporting person is the sole managing member of the family investment entity and disclaims beneficial ownership of portions in which there is no pecuniary interest.
The relationship to the issuer is marked as “Other” with the title Sr. Advisor Royce & Associates.
Royce Micro-Cap Trust, Inc. (RMT) reported an insider purchase by Christopher D. Clark on 08/26/2025. Mr. Clark acquired 2,100 shares of Common Stock at $10.16 per share, bringing his direct beneficial ownership to 59,721 shares. The Form 4 indicates the transaction code "P" (purchase) and lists Mr. Clark as a director and President of the investment adviser. The filing contains no other transactions or derivative activity.
Royce Micro-Cap Trust, Inc. solicits shareholder votes for its annual meeting and recommends reelecting Patricia W. Chadwick and Michael K. Shields as directors. The filing includes director biographies highlighting extensive investment and governance experience: Ms. Chadwick is designated an Audit Committee Financial Expert with over 30 years in investment and consulting roles; Mr. Shields has over 30 years of investment and business experience and chairs the UNC Charlotte Investment Fund Board. The document sets forth the Audit Committee charter: responsibilities include appointing and overseeing independent accountants, pre-approving audit and permissible non-audit services, reviewing audit scope and findings, handling whistleblower and legal-reporting procedures, and ensuring auditor independence and periodic written disclosures.